Compugen

CGEN · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

5 USD

Margin of Safety

+53.2 %

Rating

STARK

Compugen is an Israeli-American biotechnology company that uses computational genomics and bioinformatics to identify therapeutic targets and checkpoint candidates for cancer immunotherapy, monetizing these through licensing agreements and strategic partnerships.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.